Cite
HARVARD Citation
Matsuura, K. et al. (2022). A phase 3 safety study of fosnetupitant as an antiemetic in patients receiving anthracycline and cyclophosphamide: CONSOLE‐BC. Cancer. 128 (8), pp. 1692-1698. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Matsuura, K. et al. (2022). A phase 3 safety study of fosnetupitant as an antiemetic in patients receiving anthracycline and cyclophosphamide: CONSOLE‐BC. Cancer. 128 (8), pp. 1692-1698. [Online].